Skip to search.
 FTSE 100 Down 0.74%

Gilead Sciences Inc. (GILD)

-NasdaqGS
102.79 Down 1.04(1.00%) 3 Mar 21:00
|After Hours: : 102.70 Down 0.09 (0.09%) 00:51
Add to Portfolio
Prev Close:103.83
Open:103.84
Bid:N/A
Ask:103.55 x 200
1y Target Est:119.04
Beta:0.83
Earnings Date:20 Apr - 24 Apr (Est.)
Day's Range:102.15 - 103.90
52wk Range:63.50 - 116.83
Volume:8,348,514
Avg Vol (3m):16,373,900
Market Cap:153.10b
P/E (ttm):13.99
EPS (ttm):7.35
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 1.00%153.10b
GSKDown 0.46%114.77b
PFEDown 0.60%211.81b
RHHBYUp 1.07%N/A

Key Statistics

Forward P/E (1 yr):9.92
P/S (ttm):6.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :9.53
Quarterly EPS Est (Mar-15) :2.26
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback